Sameh Saad Ali – Short Biography 

Head of Tumor Biology Research Program, Cancer Children's Hospital 57357; March 2018-current.  Sameh.ali@57357.org, +201000026523 

Professor of Biophysics and Founding Director; up to July 2017. The Center for Aging and Associated Diseases, Helmy Institute of Medical Sciences, Zewail City of Science and Technology  Associate Professor; up to July 2017. Department of Anesthesiology, University of California San Diego 

Member in the Egyptian National Committee of Biochemistry and Molecular Biology (2018-) 

Member in the Technical Advisory Committee, Egyptian Academy of Scientific Research and Technology (2020-) 

Member in the Scientific Committee in the Egyptian Genome National Project (2020-) 

Awarded the State’s Excellence Award in Basic Sciences (2020)

Dr. Sameh Ali is currently the Unit Head of the Tumor Biology Program at 57357 Children's Cancer Hospital. Dr. Ali was the Founding Director of the Center for Aging and Associated Diseases, Helmy Institute of Medical Sciences, Zewail City of Science and Technology. He was also a Professor of Biophysics at Zewail City. Dr. Ali obtained his M.Sc. and Ph.D. Degrees from Tohoku University (ranked # 70 on the world, 2017). He spent 3 years as a postdoctoral fellow in the Technical University, Graz (ranked in the top 300, 2017) and Washington University in St. Louis (ranked # 18, 2017). He returned to Egypt from the University of California in San Diego (ranked in the top 20, 2017) June 2012 to participate in the establishment of Egypt’s National Project. Dr. Ali left the University of California as an Associate Professor in the Department of Anesthesiology (July 2017). His work produced over 60 highly cited articles (>4000 citations) in high-impact journals including Science, Proceedings of the National Academy of Sciences, Aging Cells, Antioxidant and Redox Signaling, FASEB J, J Neurosciences, Free Radical Biology and Medicine, J of Clinical Investigations, J of Biological Chemistry, J of Physiology, Neurobiology of Aging, J Adv Res, eLife, Front. Immunol., etc. His work also contributed to the production of three U.S. Patents on carboxyfullerenes as neuroprotective agents. 

Executive Editor, Editor, and regular reviewer for tens of internationally reputed journals including Cancer Research, British J. of Pharmacology, J. Biological Chemistry, etc.tific articles covering technical and philosophical aspects of the scientific method. I am a founding member of the Scientific Committee of Egypt Genome Project and a member of the Oncology and Rare Diseases subcommittees for establishing policies and action plans to analyze representative sampling of the Egyptians. As detailed in my C.V., I am also a member of multiple other national committees and have been recruited as reviewer, editor, and referee for prominent international journals and funding agencies. I have a notable presence in the Egyptian and Arab media portals with contributions highlighting scientific discoveries and methods. With nearly 100,000 followers, my Facebook page is a regular portal for scientific and philosophical articles and discussions.